REVOLUTION IN HEPATITIS C TREATMENT

  • News
  • April 21, 2016

A new strong ray of hope has come in controlling the epidemic of chronic hepatits C in various part of India which includes haryana & Punjab. Further elaborating about it, Dr. Parveen Malhotra, Head, Departmentof Medical Gastroenterology and Principal Nodal officer of Jeevan Rekha project of Haryana Government told it is the availability of combination of oral drugs i.e. Sofosbuvir with Ledipasvir/Daclatasvir at much economical prices. These drugs are being given free by to SC/BPL patients and at subsidized prices to general category patients i.e. Rs 8800/month and total Rs 26,000 for total duration of 12 weeks which is lowest not only in India but in world also. Even all the viral load and genotype testing, Endoscopy and Fibroscan are also being done free of cost. Patients suffering from hepatitis B also are being treated at a meagre price of Rs 500/month. As this disease is mainly seen in patients belonging to poor socio-economic status, thus many patients will be able to afford it who are not covered under free scheme of govt. This project is unique and has been appreciated by various international organizations like MSF and Clinton foundation. Uptill now the treatment was with Pegylated Interferon & ribavarin which has lot of side effects and cost was also more.There are many patients who never took treatment or left in between due to side effects of Pegylated Interferon. Moreover, these Pegylated interferon cannot be given or are not much successful when there is advanced liver damage but these new oral drugs are successful in all these group of patients. The Jeevan Rekha scheme of Haryana government against hepatitis C is giving new life to thousands of patients suffering from this deadly disease.Uptillnow 5000 patients have successfully completed the treatment, which makes PGIMS, Rohtak, one of the selected centers in India where such huge number of patients are being treated at on time and that too with massive success. The patients are also coming for treatment from nearby states like Punjab, Delhi, Uttarakhand and Chandigarh Moreover, round the clock, India’s first dedicated hepatitis C helpline has also been opened for needy patients (08950012900).

Related Posts

13 Years after Oxytocin Order, HC Seeks Compilance Status

GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad